UK Mortality Rates

Lord Allan of Hallam Excerpts

Thursday 12th January 2023 Grand Committee

[Lord Allan of Hallam (LD)]

My Lords, I thank the noble Lord, Lord Sikka, for tabling this debate and bringing this important paper to our attention. I look forward to hearing the Minister’s maiden speech. I made mine some time ago, but I have only recently taken up a Front-Bench position. It is quite a transition to move from Back Benches to Front Benches in terms of workload and the need to learn quickly.

I congratulate the researchers on looking into this question and on the clarity with which they have presented their findings. As content licensing is a long-standing interest of mine, I was pleased to find that this is an open-access publication, licensed under a Creative Commons licence. This maximises the opportunity for people to share and build on the work done by the team, as long as they provide the correct attribution.

The paper helps to fill out a picture which has been emerging through a number of different research projects into the harmful effects of severe cuts in government funding on life and good health expectancy, particularly the cuts which took place in the early part of the 2010s. The linkage between austerity policies and mortality rates seems clear, as described very effectively by the noble Lord, Lord Sikka, and is something that we must have top-of-mind when considering policies for the new recession which unfortunately appears to be headed our way. The noble Lord’s call for Bills to be accompanied by an assessment of the human impact was well made.

While the paper does not reach definitive conclusions on its original hypothesis that women’s mortality would have been affected more than men’s, it adds to the evidence base for austerity affecting different communities and highlights the need for continued research in the area. I hope that the Government and the Minister encourage this, as there is a tendency for Governments not to look at things that appear to criticise previous government policy, but, in this case, the public interest strongly lies in us continuing to understand what happened during that period of austerity in order to inform future policy.

While the paper looked at lifespan, with its focus on mortality rates, I want to mention the importance of looking at health span, defined as the period of life we spend in good health, free from chronic conditions and the disabilities of ageing. This builds on the comments made by both the right reverend Prelate the Bishop of London and the noble Lord, Lord Patel.

Health span is also likely to be affected by spending squeezes, especially if there are reductions in preventive health measures and delays in the treatments necessary to restore someone’s health. We can look at examples such as a delay in getting surgery to replace a hip or knee. That may not itself change your lifespan, but it certainly means more time spent living a life restricted by the health condition. This is the real cost of the increased waiting times we are seeing for elective surgery at present, which many people are sadly paying today: their health span has been reduced because they are unable to access surgery or other treatments that would enable them to live a fully healthy life again.

Similarly, a failure to provide timely advice and support to somebody who is at risk of developing type 2 diabetes may lead to them facing health problems that could have been avoided, or at least mitigated, with the provision of the right public health services. Again, any impact on their lifespan may be years down the line, but their health span is more quickly and immediately shortened. I hope the Minister’s response covers points related to health inequalities, as well as those related to mortality.

Reflecting on some of the points made by other noble Lords, the right reverend Prelate the Bishop of London rightly drew our attention to the multifactorial nature of the determinants of health. We certainly need to look at issues such as housing, as well as more obvious issues related to health treatment. The noble Lord, Lord Davies of Brixton, helped us to understand how we should look at the mortality figures. In the debate yesterday, I learned a lot about how actuaries think, and the noble Lord is providing an incredible resource for all of us in understanding how to look at the data.

I close by again looking forward to hearing the Minister’s response. I congratulate him on his arrival to the Front Bench, and I hope he will be equally supportive of encouraging and—dare I say it?—funding more research into the kinds of projects and questions looked at in this paper. It is essential from the public interest point of view that we do not shy away from difficult questions about the effect of policies on people out there, in the real world, that we and this Parliament have decided on.